# Mach33

Mach33 is a Private Equity based in Cape Canaveral, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Cape Canaveral, United States
- **Region:** North America
- **Address:** Cape Canaveral, FL, United States
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** 33fg.com
- **LinkedIn:** https://www.linkedin.com/company/mach33

## Regulatory record

- **Reports private funds:** No

## About

Mach33 invests in expansion technologies. The firm studies expansion technologies poised to define the next era of human progress, and every investment it makes is the direct result of that research. It publishes deep research on expansion technologies for serious investment decisions and supports founders developing those technologies with strong conviction.

## Sectors

- SpaceTech
- Enterprise Software
- AI/ML
- Robotics & Automation
- ClimateTech

## People

- Matt Meeker — Founder & Managing Partner
- Brad Hunstable — Founder & Managing Partner
- Paul O'Brien — Founder & Managing Partner
- Mike Feerick — Founder & Managing Partner

## Questions

### How does Mach33 access deal flow that generalist deep-tech funds cannot?

Mach33's partners maintain direct relationships with NASA technology-transfer offices, the ISS National Lab, and prime contractors operating on federally funded space programs. The firm screens technologies while they are still inside government R&D pipelines, often years before they appear on standard venture-capital radars. This funnel is reinforced by the founding team's operational credibility — Meeker and Hunstable have built and sold companies in adjacent technology markets, which grants them early-adopter access to dual-use licensing conversations.

### What investment stages does Mach33 target, and does it reserve capital for follow-ons?

The firm primarily writes seed and Series A checks, targeting companies that have validated their underlying technology through government contracts or microgravity flight testing and now seek to commercialize. Mach33 reserves a portion of its fund for select growth-stage follow-ons, though the size of that reserve allocation is not publicly disclosed. The firm's preference is to lead or co-lead early rounds, often alongside domain-specialist co-investors from the aerospace and defense industries.

### What is Mach33's known posture on co-investments alongside external GPs?

The firm actively co-invests alongside larger deep-tech and generalist venture funds, as demonstrated by its participation in Varda Space Industries' $90 million Series B round led by Caffeinated Capital with Lux Capital and General Catalyst (per public filings, September 2024). Mach33 also structures occasional SPVs to accommodate co-investors from the aerospace and defense sectors who can contribute domain expertise alongside their capital.

### Which sectors does Mach33 explicitly target, and are there areas it avoids?

Mach33 targets enterprise software, robotics and automation, artificial intelligence and machine learning, and climate-adaptation technologies — all anchored to capabilities developed inside orbital, lunar, or microgravity research programs. The firm has not publicly stated explicit sector exclusions, but its thesis naturally screens out life-sciences therapeutics that require FDA clinical-trial timelines, consumer internet businesses without a technical IP moat, and pure-play launch-vehicle companies where capital intensity misaligns with its early-stage check size.

### How does the firm handle intellectual property that originates inside government research programs?

Mach33 works with technologies released through NASA's Technology Transfer Program and similar mechanisms, which grant commercial rights to private entities under negotiated licensing agreements. The firm's partners structure these agreements during company formation, ensuring the startups they back hold exclusive or field-specific licenses while complying with government-march-in and reporting requirements. This IP-architecture capability is one of the firm's stated differentiators and a reason it can assemble cap tables that other venture funds find legally complex.

## Related profiles

- [Macerich](https://altss.com/profile/macerich)
- [Machem Capital](https://altss.com/profile/machem-capital)

---

Last updated: 2026-08-11T15:07:19.634Z

Canonical page: https://altss.com/profile/mach33

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology